181 related articles for article (PubMed ID: 19881268)
1. Potential use of 2-hydroxypropyl-beta-cyclodextrin for preparation of orally disintegrating tablets containing dl-alpha-tocopheryl acetate, an oily drug.
Motoyama K; Nagatomo K; Abd Elazim SO; Hirayama F; Uekama K; Arima H
Chem Pharm Bull (Tokyo); 2009 Nov; 57(11):1206-12. PubMed ID: 19881268
[TBL] [Abstract][Full Text] [Related]
2. Improvement of solubility and oral bioavailability of rutin by complexation with 2-hydroxypropyl-beta-cyclodextrin.
Miyake K; Arima H; Hirayama F; Yamamoto M; Horikawa T; Sumiyoshi H; Noda S; Uekama K
Pharm Dev Technol; 2000; 5(3):399-407. PubMed ID: 10934740
[TBL] [Abstract][Full Text] [Related]
3. Encapsulation and Stabilization of α-Lipoic Acid in Cyclodextrin Inclusion Complex Electrospun Nanofibers: Antioxidant and Fast-Dissolving α-Lipoic Acid/Cyclodextrin Nanofibrous Webs.
Celebioglu A; Uyar T
J Agric Food Chem; 2019 Nov; 67(47):13093-13107. PubMed ID: 31693349
[TBL] [Abstract][Full Text] [Related]
4. Improvement of solubility and oral bioavailability of 2-(N-cyanoimino)-5-[(E)-4-styrylbenzylidene]-4-oxothiazolidine (FPFS-410) with antidiabetic and lipid-lowering activities in dogs by 2-hydroxypropyl-beta-cyclodextrin.
Hara T; Hirayama F; Arima H; Yamaguchi Y; Uekama K
Chem Pharm Bull (Tokyo); 2006 Mar; 54(3):344-9. PubMed ID: 16508189
[TBL] [Abstract][Full Text] [Related]
5. [Preparation of coated tablets of glycyrrhetic acid-HP-beta-cyclodextrin tablets for colon-specific release].
Cui QH; Cui JH; Zhang JJ
Zhongguo Zhong Yao Za Zhi; 2008 Oct; 33(20):2339-43. PubMed ID: 19157122
[TBL] [Abstract][Full Text] [Related]
6. Metronidazole/Hydroxypropyl-β-Cyclodextrin inclusion complex nanofibrous webs as fast-dissolving oral drug delivery system.
Celebioglu A; Uyar T
Int J Pharm; 2019 Dec; 572():118828. PubMed ID: 31715341
[TBL] [Abstract][Full Text] [Related]
7. Manufacturing and Assessing the New Orally Disintegrating Tablets, Containing Nimodipine-hydroxypropyl-β-cyclodextrin and Nimodipine-methyl-β-cyclodextrin Inclusion Complexes.
Novac M; Musuc AM; Ozon EA; Sarbu I; Mitu MA; Rusu A; Gheorghe D; Petrescu S; Atkinson I; Lupuliasa D
Molecules; 2022 Mar; 27(6):. PubMed ID: 35335371
[TBL] [Abstract][Full Text] [Related]
8. Effect of 2-hydroxypropyl-beta-cyclodextrin on percutaneous absorption of methyl paraben.
Tanaka M; Iwata Y; Kouzuki Y; Taniguchi K; Matsuda H; Arima H; Tsuchiya S
J Pharm Pharmacol; 1995 Nov; 47(11):897-900. PubMed ID: 8708982
[TBL] [Abstract][Full Text] [Related]
9. Development of orally disintegrating tablets of Perphenazine/hydroxypropyl-β-cyclodextrin inclusion complex.
Wang L; Zeng F; Zong L
Pharm Dev Technol; 2013; 18(5):1101-10. PubMed ID: 22759202
[TBL] [Abstract][Full Text] [Related]
10. Formulation and in vivo evaluation of orally disintegrating tablets of clozapine/hydroxypropyl-β-cyclodextrin inclusion complexes.
Zeng F; Wang L; Zhang W; Shi K; Zong L
AAPS PharmSciTech; 2013 Jun; 14(2):854-60. PubMed ID: 23649995
[TBL] [Abstract][Full Text] [Related]
11. Influence of hydroxypropyl beta-cyclodextrin on the stability of benzylpenicillin in chloroacetate buffer.
Ong JK; Sunderland VB; McDonald C
J Pharm Pharmacol; 1997 Jun; 49(6):617-21. PubMed ID: 9330202
[TBL] [Abstract][Full Text] [Related]
12. Utility of 2-hydroxypropyl-beta-cyclodextrin in an intramuscular injectable preparation of nimodipine.
Yoshida A; Yamamoto M; Itoh T; Irie T; Hirayama F; Uekama K
Chem Pharm Bull (Tokyo); 1990 Jan; 38(1):176-9. PubMed ID: 2337940
[TBL] [Abstract][Full Text] [Related]
13. The influence of 2-hydroxypropyl-beta-cyclodextrin on the haemolysis induced by bile acids.
Panini R; Vandelli MA; Leo E; Salvioli G; Cameroni R
J Pharm Pharmacol; 1996 Jun; 48(6):641-4. PubMed ID: 8832501
[TBL] [Abstract][Full Text] [Related]
14. Enhancing effect of hydroxypropyl-beta-cyclodextrin on cutaneous penetration and activation of ethyl 4-biphenylyl acetate in hairless mouse skin.
Arima H; Miyaji T; Irie T; Hirayama F; Uekama K
Eur J Pharm Sci; 1998 Jan; 6(1):53-9. PubMed ID: 16256708
[TBL] [Abstract][Full Text] [Related]
15. Enhanced nasal delivery of luteinizing hormone releasing hormone agonist buserelin by oleic acid solubilized and stabilized in hydroxypropyl-beta-cyclodextrin.
Abe K; Irie T; Uekama K
Chem Pharm Bull (Tokyo); 1995 Dec; 43(12):2232-7. PubMed ID: 8582025
[TBL] [Abstract][Full Text] [Related]
16. Fast-dissolving antioxidant curcumin/cyclodextrin inclusion complex electrospun nanofibrous webs.
Celebioglu A; Uyar T
Food Chem; 2020 Jul; 317():126397. PubMed ID: 32078994
[TBL] [Abstract][Full Text] [Related]
17. Some pharmaceutical and inclusion properties of 2-hydroxybutyl-β-cyclodextrin derivative.
Ishiguro T; Morishita E; Iohara D; Hirayama F; Wada K; Motoyama K; Arima H; Uekama K
Int J Pharm; 2011 Oct; 419(1-2):161-9. PubMed ID: 21839823
[TBL] [Abstract][Full Text] [Related]
18. Inhibitory effect of 2-hydroxypropyl-beta-cyclodextrin on crystal-growth of nifedipine during storage: superior dissolution and oral bioavailability compared with polyvinylpyrrolidone K-30.
Uekama K; Ikegami K; Wang Z; Horiuchi Y; Hirayama F
J Pharm Pharmacol; 1992 Feb; 44(2):73-8. PubMed ID: 1352820
[TBL] [Abstract][Full Text] [Related]
19. Effects of aging on crystallization, dissolution and absorption characteristics of amorphous tolbutamide-2-hydroxypropyl-beta-cyclodextrin complex.
Kimura K; Hirayama F; Arima H; Uekama K
Chem Pharm Bull (Tokyo); 2000 May; 48(5):646-50. PubMed ID: 10823700
[TBL] [Abstract][Full Text] [Related]
20. Design and in-vitro evaluation of a modified-release oral dosage form of nifedipine by hybridization of hydroxypropyl-beta-cyclodextrin and hydroxypropylcellulose.
Wang Z; Horikawa T; Hirayama F; Uekama K
J Pharm Pharmacol; 1993 Nov; 45(11):942-6. PubMed ID: 7908033
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]